Enhancing the therapeutic index of concomitant chemoradiotherapy for head and neck cancer. [Ann Oncol. 1998]
Enhancing the therapeutic index of concomitant chemoradiotherapy for head and neck cancer.
Vokes EE, Pajak TF. Ann Oncol. 1998 May; 9(5):471-3.
[Head and neck: concurrent chemoradiotherapy]. [Gan To Kagaku Ryoho. 2007]
[Head and neck: concurrent chemoradiotherapy].
Higaki Y, Tomita Y. Gan To Kagaku Ryoho. 2007 Jul; 34(7):1031-3.
Review Use of chemotherapy in the management of advanced head and neck cancers. [Kans Med. 1991]
Review Use of chemotherapy in the management of advanced head and neck cancers.
Giri PG. Kans Med. 1991 Dec; 92(12):311-3, 316.
Combined radiation and chemotherapy in head and neck cancer. [Rays. 1993]
Combined radiation and chemotherapy in head and neck cancer.
Sannazzari GL, Orecchia R. Rays. 1993 Jul-Sep; 18(3):340-54.
Review Docetaxel in the management of patients with head and neck squamous cell carcinoma. [Expert Rev Anticancer Ther. 2008]
Review Docetaxel in the management of patients with head and neck squamous cell carcinoma.
Bernier J, Vrieling C. Expert Rev Anticancer Ther. 2008 Jul; 8(7):1023-32.

DNA-Platinum Thin Films for Use in Chemoradiation Therapy Studies. [Bioinorg Chem Appl. 2012]
DNA-Platinum Thin Films for Use in Chemoradiation Therapy Studies.
Rezaee M, Alizadeh E, Hunting D, Sanche L. Bioinorg Chem Appl. 2012; 2012:923914. Epub 2011 Oct 2.
Adjuvant chemoradiotherapy for locoregionally advanced and high-risk salivary gland malignancies. [Head Neck Oncol. 2011]
Adjuvant chemoradiotherapy for locoregionally advanced and high-risk salivary gland malignancies.
Pederson AW, Salama JK, Haraf DJ, Witt ME, Stenson KM, Portugal L, Seiwert T, Villaflor VM, Cohen EE, Vokes EE, et al. Head Neck Oncol. 2011 Jul 26; 3:31. Epub 2011 Jul 26.
MMP9 but Not EGFR, MET, ERCC1, P16, and P-53 Is Associated with Response to Concomitant Radiotherapy, Cetuximab, and Weekly Cisplatin in Patients with Locally Advanced Head and Neck Cancer. [J Oncol. 2009]
MMP9 but Not EGFR, MET, ERCC1, P16, and P-53 Is Associated with Response to Concomitant Radiotherapy, Cetuximab, and Weekly Cisplatin in Patients with Locally Advanced Head and Neck Cancer.
Fountzilas G, Kalogera-Fountzila A, Lambaki S, Wirtz RM, Nikolaou A, Karayannopoulou G, Bobos M, Kotoula V, Murray S, Lambropoulos A, et al. J Oncol. 2009; 2009:305908. Epub 2009 Dec 29.

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Chemoradiotherapy for locally advanced head and neck cancer.
Chemoradiotherapy for locally advanced head and neck cancer.
J Clin Oncol. 2007 Sep 10 ;25(26):4118-26.

PubMed
Genetic variation in 1253 immune and inflammation genes and risk of non-Hodgkin ...
Genetic variation in 1253 immune and inflammation genes and risk of non-Hodgkin lymphoma.
Blood. 2007 Dec 15 ;110(13):4455-63. Epub 2007 Sep 7 .

PubMed
Felodipine clinical pharmacokinetics.
Felodipine clinical pharmacokinetics.
Clin Pharmacokinet. 1991 Dec ;21(6):418-30.

PubMed
A new robust diagnostic polymerase chain reaction for determining the mating sta...
A new robust diagnostic polymerase chain reaction for determining the mating status of female Anopheles gambiae mosquitoes.
Am J Trop Med Hyg. 2007 Sep ;77(3):485-7.

PubMed
Pseudomonas syringae lytic transglycosylases coregulated with the type III secre...
Pseudomonas syringae lytic transglycosylases coregulated with the type III secretion system contribute to the translocation of effector proteins into plant cells.
J Bacteriol. 2007 Nov ;189(22):8277-89. Epub 2007 Sep 7 .

PubMed

Your browsing activity is empty.

Activity recording is turned off.

PubMed

Result Filters